Global Chronic Kidney Disease (CKD) Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

  • receipt Report ID : 147649
  • calendar_today Published On: Apr, 2019
  • file_copy Pages: 137
  • list Pharmaceuticals and Healthcare

Chronic kidney disease (CKD) is a type of kidney disease in which there is gradual loss of kidney function over a period of months or years. Early on there are typically no symptoms.

Scope of the Report:

This report focuses on the Chronic Kidney Disease (CKD) in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

The worldwide market for Chronic Kidney Disease (CKD) is expected to grow at a CAGR of roughly 4.1% over the next five years, will reach 15800 million US$ in 2023, from 12400 million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

AbbVie

Allergan

Amgen

AstraZeneca

Roche

FibroGen

GlaxoSmithKline

Johnson & Johnson

Keryx

Kissei

Pfizer

Sanofi

Teva

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Calcium channel blockers

Antihypertensive

Anemia Treatment Drugs

Others

Market Segment by Applications, can be divided into

Hospital

Clinic

There are 15 Chapters to deeply display the global Chronic Kidney Disease (CKD) market.

Chapter 1, to describe Chronic Kidney Disease (CKD) Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Chronic Kidney Disease (CKD), with sales, revenue, and price of Chronic Kidney Disease (CKD), in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Chronic Kidney Disease (CKD), for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Chronic Kidney Disease (CKD) market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Chronic Kidney Disease (CKD) sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Market Overview

1.1 Chronic Kidney Disease (CKD) Introduction

1.2 Market Analysis by Type

1.2.1 Calcium channel blockers

1.2.2 Antihypertensive

1.2.3 Anemia Treatment Drugs

1.2.4 Others

1.3 Market Analysis by Applications

1.3.1 Hospital

1.3.2 Clinic

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 AbbVie

2.1.1 Business Overview

2.1.2 Chronic Kidney Disease (CKD) Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 AbbVie Chronic Kidney Disease (CKD) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 Allergan

2.2.1 Business Overview

2.2.2 Chronic Kidney Disease (CKD) Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Allergan Chronic Kidney Disease (CKD) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 Amgen

2.3.1 Business Overview

2.3.2 Chronic Kidney Disease (CKD) Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Amgen Chronic Kidney Disease (CKD) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 AstraZeneca

2.4.1 Business Overview

2.4.2 Chronic Kidney Disease (CKD) Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 AstraZeneca Chronic Kidney Disease (CKD) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 Roche

2.5.1 Business Overview

2.5.2 Chronic Kidney Disease (CKD) Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Roche Chronic Kidney Disease (CKD) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 FibroGen

2.6.1 Business Overview

2.6.2 Chronic Kidney Disease (CKD) Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 FibroGen Chronic Kidney Disease (CKD) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7 GlaxoSmithKline

2.7.1 Business Overview

2.7.2 Chronic Kidney Disease (CKD) Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 GlaxoSmithKline Chronic Kidney Disease (CKD) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.8 Johnson & Johnson

2.8.1 Business Overview

2.8.2 Chronic Kidney Disease (CKD) Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Johnson & Johnson Chronic Kidney Disease (CKD) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.9 Keryx

2.9.1 Business Overview

2.9.2 Chronic Kidney Disease (CKD) Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Keryx Chronic Kidney Disease (CKD) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.10 Kissei

2.10.1 Business Overview

2.10.2 Chronic Kidney Disease (CKD) Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Kissei Chronic Kidney Disease (CKD) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.11 Pfizer

2.11.1 Business Overview

2.11.2 Chronic Kidney Disease (CKD) Type and Applications

2.11.2.1 Product A

2.11.2.2 Product B

2.11.3 Pfizer Chronic Kidney Disease (CKD) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.12 Sanofi

2.12.1 Business Overview

2.12.2 Chronic Kidney Disease (CKD) Type and Applications

2.12.2.1 Product A

2.12.2.2 Product B

2.12.3 Sanofi Chronic Kidney Disease (CKD) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.13 Teva

2.13.1 Business Overview

2.13.2 Chronic Kidney Disease (CKD) Type and Applications

2.13.2.1 Product A

2.13.2.2 Product B

2.13.3 Teva Chronic Kidney Disease (CKD) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Chronic Kidney Disease (CKD) Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Chronic Kidney Disease (CKD) Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Chronic Kidney Disease (CKD) Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Chronic Kidney Disease (CKD) Manufacturer Market Share in 2017

3.3.2 Top 6 Chronic Kidney Disease (CKD) Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Chronic Kidney Disease (CKD) Market Analysis by Regions

4.1 Global Chronic Kidney Disease (CKD) Sales, Revenue and Market Share by Regions

4.1.1 Global Chronic Kidney Disease (CKD) Sales and Market Share by Regions (2013-2018)

4.1.2 Global Chronic Kidney Disease (CKD) Revenue and Market Share by Regions (2013-2018)

4.2 North America Chronic Kidney Disease (CKD) Sales and Growth Rate (2013-2018)

4.3 Europe Chronic Kidney Disease (CKD) Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Chronic Kidney Disease (CKD) Sales and Growth Rate (2013-2018)

4.5 South America Chronic Kidney Disease (CKD) Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Chronic Kidney Disease (CKD) Sales and Growth Rate (2013-2018)

5 North America Chronic Kidney Disease (CKD) by Countries

5.1 North America Chronic Kidney Disease (CKD) Sales, Revenue and Market Share by Countries

5.1.1 North America Chronic Kidney Disease (CKD) Sales and Market Share by Countries (2013-2018)

5.1.2 North America Chronic Kidney Disease (CKD) Revenue and Market Share by Countries (2013-2018)

5.2 United States Chronic Kidney Disease (CKD) Sales and Growth Rate (2013-2018)

5.3 Canada Chronic Kidney Disease (CKD) Sales and Growth Rate (2013-2018)

5.4 Mexico Chronic Kidney Disease (CKD) Sales and Growth Rate (2013-2018)

6 Europe Chronic Kidney Disease (CKD) by Countries

6.1 Europe Chronic Kidney Disease (CKD) Sales, Revenue and Market Share by Countries

6.1.1 Europe Chronic Kidney Disease (CKD) Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Chronic Kidney Disease (CKD) Revenue and Market Share by Countries (2013-2018)

6.2 Germany Chronic Kidney Disease (CKD) Sales and Growth Rate (2013-2018)

6.3 UK Chronic Kidney Disease (CKD) Sales and Growth Rate (2013-2018)

6.4 France Chronic Kidney Disease (CKD) Sales and Growth Rate (2013-2018)

6.5 Russia Chronic Kidney Disease (CKD) Sales and Growth Rate (2013-2018)

6.6 Italy Chronic Kidney Disease (CKD) Sales and Growth Rate (2013-2018)

7 Asia-Pacific Chronic Kidney Disease (CKD) by Countries

7.1 Asia-Pacific Chronic Kidney Disease (CKD) Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Chronic Kidney Disease (CKD) Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Chronic Kidney Disease (CKD) Revenue and Market Share by Countries (2013-2018)

7.2 China Chronic Kidney Disease (CKD) Sales and Growth Rate (2013-2018)

7.3 Japan Chronic Kidney Disease (CKD) Sales and Growth Rate (2013-2018)

7.4 Korea Chronic Kidney Disease (CKD) Sales and Growth Rate (2013-2018)

7.5 India Chronic Kidney Disease (CKD) Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Chronic Kidney Disease (CKD) Sales and Growth Rate (2013-2018)

8 South America Chronic Kidney Disease (CKD) by Countries

8.1 South America Chronic Kidney Disease (CKD) Sales, Revenue and Market Share by Countries

8.1.1 South America Chronic Kidney Disease (CKD) Sales and Market Share by Countries (2013-2018)

8.1.2 South America Chronic Kidney Disease (CKD) Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Chronic Kidney Disease (CKD) Sales and Growth Rate (2013-2018)

8.3 Argentina Chronic Kidney Disease (CKD) Sales and Growth Rate (2013-2018)

8.4 Colombia Chronic Kidney Disease (CKD) Sales and Growth Rate (2013-2018)

9 Middle East and Africa Chronic Kidney Disease (CKD) by Countries

9.1 Middle East and Africa Chronic Kidney Disease (CKD) Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Chronic Kidney Disease (CKD) Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Chronic Kidney Disease (CKD) Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Chronic Kidney Disease (CKD) Sales and Growth Rate (2013-2018)

9.3 UAE Chronic Kidney Disease (CKD) Sales and Growth Rate (2013-2018)

9.4 Egypt Chronic Kidney Disease (CKD) Sales and Growth Rate (2013-2018)

9.5 Nigeria Chronic Kidney Disease (CKD) Sales and Growth Rate (2013-2018)

9.6 South Africa Chronic Kidney Disease (CKD) Sales and Growth Rate (2013-2018)

10 Global Chronic Kidney Disease (CKD) Market Segment by Type

10.1 Global Chronic Kidney Disease (CKD) Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Chronic Kidney Disease (CKD) Sales and Market Share by Type (2013-2018)

10.1.2 Global Chronic Kidney Disease (CKD) Revenue and Market Share by Type (2013-2018)

10.2 Calcium channel blockers Sales Growth and Price

10.2.1 Global Calcium channel blockers Sales Growth (2013-2018)

10.2.2 Global Calcium channel blockers Price (2013-2018)

10.3 Antihypertensive Sales Growth and Price

10.3.1 Global Antihypertensive Sales Growth (2013-2018)

10.3.2 Global Antihypertensive Price (2013-2018)

10.4 Anemia Treatment Drugs Sales Growth and Price

10.4.1 Global Anemia Treatment Drugs Sales Growth (2013-2018)

10.4.2 Global Anemia Treatment Drugs Price (2013-2018)

10.5 Others Sales Growth and Price

10.5.1 Global Others Sales Growth (2013-2018)

10.5.2 Global Others Price (2013-2018)

11 Global Chronic Kidney Disease (CKD) Market Segment by Application

11.1 Global Chronic Kidney Disease (CKD) Sales Market Share by Application (2013-2018)

11.2 Hospital Sales Growth (2013-2018)

11.3 Clinic Sales Growth (2013-2018)

12 Chronic Kidney Disease (CKD) Market Forecast (2018-2023)

12.1 Global Chronic Kidney Disease (CKD) Sales, Revenue and Growth Rate (2018-2023)

12.2 Chronic Kidney Disease (CKD) Market Forecast by Regions (2018-2023)

12.2.1 North America Chronic Kidney Disease (CKD) Market Forecast (2018-2023)

12.2.2 Europe Chronic Kidney Disease (CKD) Market Forecast (2018-2023)

12.2.3 Asia-Pacific Chronic Kidney Disease (CKD) Market Forecast (2018-2023)

12.2.4 South America Chronic Kidney Disease (CKD) Market Forecast (2018-2023)

12.2.5 Middle East and Africa Chronic Kidney Disease (CKD) Market Forecast (2018-2023)

12.3 Chronic Kidney Disease (CKD) Market Forecast by Type (2018-2023)

12.3.1 Global Chronic Kidney Disease (CKD) Sales Forecast by Type (2018-2023)

12.3.2 Global Chronic Kidney Disease (CKD) Market Share Forecast by Type (2018-2023)

12.4 Chronic Kidney Disease (CKD) Market Forecast by Application (2018-2023)

12.4.1 Global Chronic Kidney Disease (CKD) Sales Forecast by Application (2018-2023)

12.4.2 Global Chronic Kidney Disease (CKD) Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures

Figure Chronic Kidney Disease (CKD) Picture

Table Product Specifications of Chronic Kidney Disease (CKD)

Figure Global Sales Market Share of Chronic Kidney Disease (CKD) by

Please fill the form below, to recieve the report sample


+1

Choose License Type

Reach Us

Email us at

sales@mrinsights.biz

Or call us on

US +1-201-465-4211

IND +91-906-779-0957

Why Choose Us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery